Clinical Trials Logo

Clinical Trial Summary

Dehydration lowers both physical and mental performance if it is severe enough. Performance declines are more pronounced in hot conditions or after prolonged strenuous activity such as exercise. Most individuals drink less than their sweat losses during activity, while some individuals overdrink and develop a sodium deficiency. Water and electrolyte balance must be restored as part of the recovery process after any activity that causes sweating. Plain water causes a decrease in plasma sodium concentration and osmolality, which reduces the desire to drink and increases urine production. Unless the volume ingested exceeds the loss, individuals are in net negative fluid balance throughout the recovery period due to urinary losses. When sodium and potassium are added to rehydration fluids, urine production is reduced in the hours following rehydration. Rehydration is only possible if a volume of fluid equal to or greater than the amount lost through sweat is consumed, together with adequate electrolytes. The two test products for this study, are novel hydration beverage formulas. They are an electrolyte drink mixture with five essential vitamins and three times more electrolytes than typical sports beverages. The test products create an osmotic force that permits water to be supplied to the bloodstream sooner in the digestive system by using a specific ratio of sodium, glucose, and potassium. This randomized, placebo-controlled, semi-blind, crossover study will evaluate the effects of the test products on rehydration in healthy adults.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05428774
Study type Interventional
Source Liquid I.V.
Contact
Status Completed
Phase N/A
Start date August 1, 2022
Completion date January 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT05092854 - The Effect of AMP Human Sodium Bicarbonate Lotion on Dehydrated Heat Stress N/A
Completed NCT05111392 - Hydration Dynamics and Influence of Beverage Composition Phase 1/Phase 2
Completed NCT04637308 - Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy Phase 2
Completed NCT05391607 - Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement Phase 4
Completed NCT03080831 - TOnicity of Perioperative Maintenance SoluTions Phase 4
Completed NCT03848507 - Impact of Hyperoncotic Albumin to Support Blood Loss Replacement Phase 4
Completed NCT04598386 - The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration N/A
Not yet recruiting NCT05786248 - MOdification of Fluid Distribution In 90 Minutes N/A
Recruiting NCT04193995 - Intermittent Fasting as a Means to Lose Fluid Overload and Weight in Complicated Obesity N/A